Janux Therapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+2.02M	23.2%	$39.05	+$79M
Sells	6	-6.7M	76.8%	$51.19	-$343M
Net	-5	-4.67M	-53.6%		-$264M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Avalon Ventures XI, L.P.	10%+ Owner	$347M	-$205M	-37.2%	Oct 16, 2024
Ra Capital Management, L.P.	Director, 10%+ Owner	$315M	+$79M	+33.6%	Mar 5, 2025
Jay Lichter	10%+ Owner	$294M	-$82.3M	-21.9%	Sep 13, 2024
Tighe Reardon	Acting Chief Financial Officer	$227M	-$45M	-16.5%	Jun 3, 2024
Bregua Corp	10%+ Owner	$22M			Jun 15, 2021
David Alan Campbell	President and CEO, Director	$17.6M	-$6.5M	-27%	Jan 7, 2025
Thomas DiRaimondo	Chief Scientific Officer	$7.44M	-$232K	-3.02%	Jan 2, 2025
Sheila Gujrathi	Director	$6.21M			Nov 5, 2024
Charles M. Winter	Chief Technical Officer	$4.43M			Jan 2, 2025
Vickie L. Capps	Director	$3.79M			Nov 5, 2024
Andrew Hollman Meyer	Chief Business Officer	$2.7M	-$3.28M	-54.8%	Mar 3, 2025
Byron Robinson	Chief Strategy Officer	$1.61M			Jan 2, 2025
Zachariah McIver	Chief Medical Officer	$1.49M			Jan 2, 2025
Orbimed Advisors Llc	Director	$1.36M			Dec 29, 2021
Peter A. Thompson	Director	$1.36M			Jun 14, 2022
Maria Dobek	Vice President, Accounting	$803K			Jan 2, 2025
Eric Dobmeier	Director	$341K			Jul 19, 2024
Natasha Hernday	Director	$341K			Jul 19, 2024
Winston Kung	Director	$137K			Jun 26, 2024
Ronald W. Barrett	Director	$137K			Jun 26, 2024
Alana B. McNulty	Director	$137K			Jun 26, 2024
Jake Simson	Director	$137K			Jun 26, 2024
Shahram Salek-Ardakani	Chief Scientific Officer				Jan 3, 2022
Stefan Heller	Director				Jun 14, 2022
Wayne Godfrey	Chief Medical Officer				Jan 3, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.